MedPath

北海康成(上海)生物科技有限公司

Ownership
-
Established
2016-06-22
Employees
-
Market Cap
-
Website
https://www.canbridgepharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Velaglucerase beta for Injection

Product Name
戈芮宁
Approval Number
国药准字S20250020
Approval Date
May 13, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.